Produkty 2000206-95-9

CAS 2000206-95-9 występuje w naszej ofercie pod nazwami: (3b,13a)-17-Methyleneandrost-5-en-3-ol, (3Beta,13Alpha)-17-Methyleneandrost-5-en-3-ol. Oferty producentów: TRC. Dostępne opakowania: 1g, 250mg, 500mg.

(3b,13a)-17-Methyleneandrost-5-en-3-ol
TRC
  • opakowanie: 1g
  • Warianty: 1
Zobacz produkt
(3Beta,13Alpha)-17-Methyleneandrost-5-en-3-ol
TRC
  • opakowanie: 250mg, 500mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,8S,9S,10R,13R,14S)-10,13-dimethyl-17-methylidene-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol (CAS 2000206-95-9) to związek chemiczny o wzorze sumarycznym C20H30O i masie molowej 286.5 g/mol. Nazwa systematyczna IUPAC: (3S,8S,9S,10R,13R,14S)-10,13-dimethyl-17-methylidene-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol. InChIKey: CDCQHKMEOJJEBD-RABCQHRBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H30O
Masa molowa286.5 g/mol
Nazwa IUPAC(3S,8S,9S,10R,13R,14S)-10,13-dimethyl-17-methylidene-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol
InChIKeyCDCQHKMEOJJEBD-RABCQHRBSA-N
SMILESC[C@@]12CC[C@H]3[C@H]([C@@H]1CCC2=C)CC=C4[C@@]3(CC[C@@H](C4)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (3b,13a)-17-Methyleneandrost-5-en-3-ol
Powiązane formy tego związku
(3S,8S,9S,10R,13S,14S)-10,13-dimethyl-17-methylidene-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-ol C20H30O
Izomery (ten sam wzór sumaryczny)
(4bS,8aS)-4b,8,8-trimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-ol C20H30O
(3S,8R,9S,10R,13S,14S)-3,10,13-trimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C20H30O
(3E,5E,7E,9Z)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-2-en-1-ylidene)nona-3,5,7-trien-1-ol C20H30O
(2Z,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O
(2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O
(1S,4S,5R,9S,10R,13R)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carbaldehyde C20H30O
(5S,8R,9S,10S,13S,14S)-10,13,17-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one C20H30O
(4bS,8aS)-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-3-ol C20H30O
(5S,8R,9S,10S,13S,14S)-2,10,13-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C20H30O